Skip to main content
. 2019 Jul 11;11:6477–6487. doi: 10.2147/CMAR.S209634

Table S1.

Summary of characteristics distribution in BCS or mastectomy underwent postoperative radiotherapy before and after PSM

Characteristics BCS n=379 Mastectomy n=397 P-value BCS n=196 Mastectomy n=196 P-value
N % N % N % N %
Before PSM After PSM
Age (years) 0.315 1.000
 ≤40 93 24.5 110 27.7 47 24.0 47 24.0
 >40 286 75.5 287 72.3 149 76.0 149 76.0
Primary tumor site 0.001 1.000
 OQ 287 75.7 271 68.3 153 78.1 153 78.1
 IQ/CQ 84 22.2 96 24.2 40 20.4 40 20.4
 Unknown 8 2.1 30 7.5 3 1.5 3 1.5
Menopausal status 0.057 1.000
 Premenopausal/perimenopause 239 63.1 276 69.5 138 70.4 138 70.4
 Postmenopausal 140 36.9 121 30.5 58 29.6 58 29.6
Tumor size 0.000 1.000
 ≤3 cm 348 91.8 300 83.5 243 88.7 243 88.7
 >3 cm 31 8.2 97 16.5 31 11.3 31 11.3
Number of positive axillary LNs 0.000 1.000
 1–2 328 86.5 297 74.8 170 86.7 170 86.7
 3 51 13.5 100 25.2 26 13.3 26 13.3
Histological grade 0.568 1.000
 I/II 226 59.6 222 55.9 119 60.7 119 60.7
 III 145 38.3 165 41.6 75 38.3 75 38.3
 Unknown 8 2.1 10 2.5 2 2.9 2 2.9
Lymphovascular invasion status 0.433 1.000
 No 231 60.9 231 58.2 166 60.6 166 60.6
 Yes 148 39.1 166 41.8 108 39.4 108 39.4
Molecular subtype 0.000 1.000
 Luminal A 118 31.1 73 18.4 52 26.5 52 26.5
 Luminal B/Her-2 - 154 40.6 143 36.0 82 41.8 82 41.8
 Luminal B/Her-2+ 66 17.4 82 20.7 38 19.4 38 19.4
 Her-2 enriched 12 3.2 39 9.8 5 2.6 5 2.6
 TNBC 29 7.7 60 15.1 19 9.7 19 9.7

Note: P-values were calculated using chi-square test.

Abbreviations: BCS, breast conserving surgery; PSM, propensity score match; OQ, outer quadrant; IQ, inner quadrant; CQ, central quadrant; LN, lymph node; LVI, lymphovascular invasion; Her-2, human epidermal growth factor receptor-2; TNBC, triple-negative breast cancer.